For individuals with BMI above 30 or BMI above 27 with comorbidities, FDA-approved GLP-1 receptor agonists (semaglutide, tirzepatide) have far stronger evidence and produce dramatically greater weight loss
Metabolic Health & Weight Loss GLP-1 therapy, glucose optimization, body composition Hormone Optimization TRT, HRT, thyroid, and hormonal balance Recovery & Healing Injury recovery, tissue repair, inflammation Cognitive Enhancement Focus, memory, mental clarity, neuroprotection Longevity & Anti-Aging Cellular health, NAD+, lifespan optimization Athletic Performance Strength, endurance, training optimization
Interestingly, much of the research has been based on doses far exceeding the recommended daily intake, both in individuals with pathological conditions and in healthy subjects
Documentation, not claims Every batch of the KLOW blend ships with a verified certificate of analysis (COA) confirming identity and purity